Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach

Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach

Hepatocellular carcinoma (HCC) is a leading global cause of cancer-related mortality. Despite the widespread adoption of sorafenib as the standard HCC treatment, its efficacy is constrained, frequently encountering resistance. To augment the effectiveness of sorafenib, this study investigated the sy...

Full description

Bibliographic Details
Main Authors: Wai Har Ng, Khee Chee Soo, Hung Huynh
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
hepatocellular carcinoma
sorafenib
vinorelbine
antitumor growth
patient-derived xenograft
focal adhesion kinase
Online Access:https://www.mdpi.com/1422-0067/25/3/1563

Internet

https://www.mdpi.com/1422-0067/25/3/1563

Similar Items